Listen to the conversation as they discuss:

  • How health equity is a key component of Thermo Fisher’s core business.
  • How Thermo Fisher leverages its capabilities and customer relationships to further its impact.
  • Initiatives that improve health equity through accessibility to drug-resistant HIV testing, next-generation sequencing to diagnose lung and breast cancer in 30 underserved countries, increasing the accessibility to and diversity in clinical trials, and more.
  • New programs in 2024.

Podden och tillhörande omslagsbild på den här sidan tillhör Thermo Fisher. Innehållet i podden är skapat av Thermo Fisher och inte av, eller tillsammans med, Poddtoppen.